Randomized Phase 1-2 Study to Assess Safety and Efficacy of Low-Dose (LD) Oral Decitabine/ Cedazuridine (ASTX727) in Lower-Risk Myelodysplastic Syndromes (LR-MDS) Patients: Interim Safety Analysis Guillermo Garcia-Manero , Kimo Bachiashvili , Elizabeth A. Griffiths , Amer M. Zeidan , Elie Traer , Lalit Saini , Harshad Amin , Sanjay Mohan , Michael Lubbert , Lori Maness-Harris , James Foran , Dominik Selleslag , Blanca Xicoy , Daniel A. Pollyea , David A. Sallman , Aref Al-Kali , Jesus G. Berdeja , Haifa Al-Ali , Nancy Y. Zhu , Patricia Font Lopez , Guillermo Sanz Santillana , Valeria Santini , Habte Yimer , Larry D. Cripe , Victor Priego , Olatoyosi Odenike , Bert Heyrman , David Valcarcel Ferreiras , Pankit J. Vachhni , Winny Chan , Yuri Sano , Beloo Mirakhur , Aram Oganesian , Harold Keer , Abdulraheem Yacoub CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
AI 理解论文
溯源树
样例